181 related articles for article (PubMed ID: 24521767)
1. Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis.
Barnado A; Kamen DL
Am J Med Sci; 2014 Mar; 347(3):256-7. PubMed ID: 24521767
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients.
Micheloud D; Calderón M; Caparrros M; D'Cruz DP
Ann Rheum Dis; 2007 Jul; 66(7):986-7. PubMed ID: 17576788
[No Abstract] [Full Text] [Related]
3. [Off-label use of intravenous immunoglobulin therapy in the treatment of lupus myocarditis: Two case reports and literature review].
Charhon N; Bernard C; Richard JC; Cordel N; Leboucher G; Broussolle C; Sève P
Rev Med Interne; 2017 Mar; 38(3):204-209. PubMed ID: 27263120
[TBL] [Abstract][Full Text] [Related]
4. Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy.
Suri V; Varma S; Joshi K; Malhotra P; Kumari S; Jain S
Rheumatol Int; 2010 Sep; 30(11):1503-5. PubMed ID: 19697032
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
[TBL] [Abstract][Full Text] [Related]
6. Severe Lupus Myocarditis Preceded by Mesalazine-induced Lupus.
Yamashita M; Nishimura K; Shirasugi I; Ichise Y; Ueda Y; Saegusa J
Intern Med; 2023 Mar; 62(6):929-933. PubMed ID: 35945022
[TBL] [Abstract][Full Text] [Related]
7. [Adult-onset Still's disease with pulmonary and cardiac involvement and response to intravenous immunoglobulin].
Neto NS; Waldrich L; de Carvalho JF; Pereira RM
Acta Reumatol Port; 2009; 34(4):628-32. PubMed ID: 20087268
[TBL] [Abstract][Full Text] [Related]
8. Orbital myositis as manifestation of systemic lupus erythematosus--a case report.
Santosa A; Vasoo S
Postgrad Med J; 2013 Jan; 89(1047):59. PubMed ID: 22967713
[No Abstract] [Full Text] [Related]
9. Successful intravenous immunoglobulin therapy in a case of acute fulminant myocarditis.
Ozyiğit T; Unal Z; Ozben B
Turk Kardiyol Dern Ars; 2011 Jan; 39(1):59-63. PubMed ID: 21358234
[TBL] [Abstract][Full Text] [Related]
10. Cerebral haemorrhage in a patient with systemic lupus erythematosus and vasculitis treated with intravenous immunoglobulins for a long-time and in absence of other risk factors.
Giannitti C; Cerase A; Miracco C; Fioravanti A
Clin Ter; 2011; 162(2):125-7. PubMed ID: 21533318
[TBL] [Abstract][Full Text] [Related]
11. Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
Thomas G; Cohen Aubart F; Chiche L; Haroche J; Hié M; Hervier B; Costedoat-Chalumeau N; Mazodier K; Ebbo M; Cluzel P; Cordel N; Ribes D; Chastre J; Schleinitz N; Veit V; Piette JC; Harlé JR; Combes A; Amoura Z
J Rheumatol; 2017 Jan; 44(1):24-32. PubMed ID: 28042125
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus.
Konda S; Fernandez AP; Berman B; Elgart G; Milikowski C; Alonso-Llamazares J
Int J Dermatol; 2011 Oct; 50(10):1270-5. PubMed ID: 21950295
[No Abstract] [Full Text] [Related]
13. Thrombopoietin receptor agonist, splenectomy and intravenous immunoglobulin for immune thrombocytopaenia with systemic lupus erythematosus.
Sofue H; Kida T; Seno T; Kohno M; Kawahito Y
Rheumatology (Oxford); 2018 Aug; 57(8):1495-1497. PubMed ID: 29579273
[No Abstract] [Full Text] [Related]
14. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.
Martínez T; Garcia-Robledo JE; Plata I; Urbano MA; Posso-Osorio I; Rios-Serna LJ; Barrera MC; Tobón GJ
Autoimmun Rev; 2019 Mar; 18(3):279-286. PubMed ID: 30639648
[TBL] [Abstract][Full Text] [Related]
15. Intravenous human immunoglobulin for the treatment of recurrent focal myositis.
Santos-Faria D; Sousa-Neves J; Leite Silva J; Ramos Rodrigues J; Azevedo S; Alcino S; Afonso C; Teixeira F
Acta Reumatol Port; 2019; 44(1):88-89. PubMed ID: 31249282
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous immunoglobulins in the systemic autoinmune diseases].
Gómez-Puerta JA; Cucho Venegas M; Cervera Segura R; Font Franco J
Rev Clin Esp; 2003 Nov; 203(11):548-54. PubMed ID: 14599398
[No Abstract] [Full Text] [Related]
17. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
19. Reversible cardiogenic shock in a patient with lupus myocarditis.
Disla E; Rhim HR; Reddy A; Ramaprasad S; Taranta A
J Rheumatol; 1993 Dec; 20(12):2174. PubMed ID: 8014958
[No Abstract] [Full Text] [Related]
20. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
Lazurova I; Macejova Z; Benhatchi K; Oetterová M; Antolová E; Asherson RA; Rovensky J
Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
